Dr Lal PathLabs Quality and Service is now being made available at your fingertips via our Mobile App, which has been made with utmost care and the objective of keeping it simple yet effective. Key features of the app include: 1. Book a Home Collection: Now you can book right from the...
Dr. Lal PathLabs LimitedDr. Lal PathLabs Limited4.1 Disclosure by Directors and KMP's Every year, the Directors shall provide declaration to the Company Secretary his concern or interest in any Company or Companies or bodies corporate, firms, or other association of individuals in the format...
Dr Lal PathLabs, Alkem Labs IPOs priced on the higher sideLisa Pallavi Barbora
Dr Lal PathLabs Quality and Service is now being made available at your fingertips via our Mobile App which has been made with utmost care and the objective of keeping it simple yet effective. Key features of the app include: - Book a Test: Now you can book a home collection right from...
How can I download my report from the Dr. B. Lal Lab website ? How do I find the nearest Dr. B. Lal medical labs ? How do I book lab tests online at Dr. B. Lal Lab ? What are the most commonly performed diagnostic tests ? Why should I choose Dr. B. Lal Lab ?Popular Tests...
Dr. Lal PathLabs的远期市盈增长比率是2.42 接下来 5 个财年,Dr. Lal PathLabs的预估远期市盈增长比率均值是 2.48。 接下来5个财年,Dr. Lal PathLabs的远期市盈增长比率中值是2.42。 相比竞争对手,Dr. Lal PathLabs的远期市盈增长比率基准如何? 我们发现下列公司与Dr. Lal PathLabs Ltd相近,它们都属于相关的行...
Dr. Lal PathLabs Ltd的交易量(仅交易日)排名为第223.425 K名,处于板块内37.5%的水平。下表提供了更多数据的摘要: 板块医疗保健的交易量(仅交易日) 经济风险区类别发展中 全部成分股1,229 包括的成分股1,179 分钟0.265 K 最大值33.727 M 中位数891.784 K ...
Dr Lal PathLabs Ltd (LPL) 成立于1949 年,是印度的一家大型私营临床诊断公司,在全球运营230多家实验室,每年为2500万名客户提供4000 多项诊断测试及相关健康检查和服务。LPL 专注于为患者和医生提供优质、快速和高效的测试服务,并与印度3700多家患者服务中心和9000个服务点协调合作。2017年至2018年,公司开始将业务...
said Bharath Uppiliappan, CEO, Dr. Lal PathLabs. ?Understanding the criticality of response and resolution time in the healthcare industry, and efficiently managing it through its multi-cloud management solution has been Kyndryl?s significant contribution. From seamlessly managing...
Dr. Lal PathLabs Ltd的日度技术指标评级是强力买入,有5个买入信号和2个卖出信号。 DLPA的14日RSI是多少? DLPA当前的14日相对强弱指标(RSI)是51.742,表示对股票的评级是中性。 DLPA的MACD情况如何? DLPA的MACD是0.140,表示对股票的评级是买入。 DLPA的5日移动均线情况如何? DLPA的5日移动均线是2804.23,表示对股...